Automated Assessment of PVI Using a Novel EP Recording System

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 101 participants.

Also called NCT05043883

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 101 participants (enrolled count) (from the registry)
Sponsor
CathVision ApS (from the registry)
Registry
  • NCT NCT05043883
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Belgium, France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05043883. Allocation not applicable; no masking; primary purpose treatment. Start 2021-09-15 (actual); primary completion 2022-06-22 (actual). Results posted on 2024-08-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Automated Assessment of PVI Using a Novel EP Recording System
Acronym
PVISION
Condition
Paroxysmal Atrial Fibrillation
Condition
Persistent Atrial Fibrillation
Intervention (Device)
CathVision Cube® system
Lead sponsor
CathVision ApS (class: industry)
Collaborator
AKRN Scientific Consulting, S.L. (class: industry)

Record details

Record id
cardio:ct-nct05043883
Content hash
38fcda24ed6d5baa3d4124a41a8a28e1d15674ed6a353670c0d2c5f4a630b01e